Browsing Modes for Business Users

Kappa Light Chain antibody

ISO 9001 Quality Assurance Manufacturing | Print
Anti Human Kappa Light Chain Antibody thumbnail image 1 Anti Human Kappa Light Chain Antibody thumbnail image 2
Anti Human Kappa Light Chain Antibody gallery image 1
Published customer image:
Horseradish peroxidase conjugated Goat anti Human kappa light chain antibody (STAR127P) used to evaluate Vedolizumab levels in serum by ELISA.
Image caption:
Vedolizumab discontinuation trough levels in association with response to subsequent all non-surgical therapy (a) and anti-TNF therapy (b) at 6 and 12 months post discontinuation. Data presented as median and IQR. TNF—Tumor necrosis factor.

From: Levartovsky A, Cohen I, Abitbol CM, Yavzori M, Fudim E, Picard O, Kopylov U, Ben-Horin S, Ungar B.
Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
Biomedicines. 2023 May 26;11(6):1553.
doi: 10.3390/biomedicines11061553. .
This image is from an open access article distributed under terms of a Creative Commons Attribution License.
Anti Human Kappa Light Chain Antibody gallery image 2
Published customer image:
Goat anti Human Kappa Light Chain antibody (STAR127P) used as a detection reagent in an ELISA for the evaluation of vedolizumab levels in patient sera.
Image caption:
Association between vedolizumab serum drug levels and the reporting of adverse events (AEs). (a) Association between vedolizumab levels and reporting of at least one AE. (b) Association between vedolizumab levels and reporting of at least one AE, excluding fatigue and abdominal pain. (c) Association between vedolizumab trough levels of below or above 18 µg/mL and reporting of at least one AE. Abbreviations: AE = adverse event; and TL = trough level.

From: Veisman I, Barzilay O, Bruckmayer L, Haj-Natour O, Kopylov U, Eliakim R, Ben-Horin S, Ungar B.
Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study.
J Clin Med. 2021 Sep 20;10(18):4265.
doi: 10.3390/jcm10184265.
This image is from an open access article distributed under terms of a Creative Commons Attribution License.

Goat anti Human Kappa Light Chain

Product Type
Polyclonal Antibody
Isotype
Polyclonal IgG
Specificity
Kappa Light Chain

Quick Links:

 Antibody Quality and Performance Guarantee
 Unrivaled Technical Support
Product Code Applications Pack Size List Price Your Price Qty
STAR127
Datasheet Datasheet Datasheet
SDS Safety Datasheet SDS
E 1 mg loader
List Price Your Price
loader

Goat anti Human Kappa Light Chain antibody recognizes human kappa light chains. This antibody has been cross absorbed against pooled human myeloma proteins with lambda light chains.

Target Species
Human
Product Form
Purified IgG - liquid
Antiserum Preparation
Antisera to human kappa chains were raised by repeated immunisation of goats with purified antigen. Purified IgG was prepared from whole serum by affinity chromatography.
Buffer Solution
Borate buffered saline
Preservative Stabilisers
<0.1% Sodium Azide (NaN3)
Immunogen
Human kappa light chain
Approx. Protein Concentrations
IgG concentration 1.0mg/ml
Regulatory
For research purposes only
Guarantee
12 months from date of despatch

This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.

Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
ELISA
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.

Description Product Code Applications Pack Size List Price Your Price Quantity
Rabbit anti Goat IgG (Fc):FITC STAR122F F 1 mg loader
List Price Your Price
loader
Description Rabbit anti Goat IgG (Fc):FITC
Rabbit anti Goat IgG (Fc):HRP STAR122P C E WB 1 mg loader
List Price Your Price
loader
Description Rabbit anti Goat IgG (Fc):HRP

References for Kappa Light Chain antibody

  1. Veisman, I. et al. (2021) Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study.
    J Clin Med. 10 (18): 4265.
  2. Ungar, B. et al. (2021) Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms.
    J Crohns Colitis. 15 (10): 1707-19.
  3. Levartovsky, A. et al. (2023) Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
    Biomedicines. 11 (6): 1553.

RRID
AB_1102708
UniProt
P01834
Entrez Gene
IGKC
GO Terms
GO:0005515 protein binding
GO:0003823 antigen binding
GO:0005576 extracellular region
GO:0006958 complement activation, classical pathway
GO:0045087 innate immune response

STAR127

149973

If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.

View more products with KAPPA LIGHT CHAIN specificity

Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"

View all Anti-Human Products
Please note